Transform fragmented clinical sample data into scalable enterprise architecture

Trusted by multiple top pharmas, QuartzBio Sample Intelligence closes the clinical sample data governance gap in your R&D architecture, empowering IT teams with a platform that’s harmonized, vendor-agnostic, and built for enterprise scale.

View the hidden costs of fragmented sample data in clinical trials:

View white paper

Fragmented sample data is your architecture’s blind spot–invisible, until it breaks.

R&D IT leaders at global biopharmas are responsible for the data infrastructure that enables clinical development. But sample data consistently falls outside the governed layer.

Across globally distributed vendors, labs, and studies,

Sample data lives in disconnected systems and formats, hiding risk
Governance and standardization are inconsistent
Integration approaches vary, leading to exponentially increasing overhead across vendors
Architecture becomes harder to evolve over time

Fragmented across dozens of vendor-specific systems, manual spreadsheets, and point-to-point integrations, sample data represents both a governance gap and a strategic liability.

How R&D IT leaders close the architecture gap with Sample Intelligence:

Standardize without disruption
Introduce a governed sample data layer without replacing existing systems.
Scale architecture across new studies, vendors, even therapeutic areas without adding new integration paths
Unlock harmonized sample data at enterprise scale
High-quality sample data ready for advanced analytics and AI initiatives.
Reduce architectural fragility and point-to point integrations
Replace inconsistent sample data pipelines with a stable, governed foundation.
Ensure interoperability across your ecosystem
Consistent APIs and formats that connect seamlessly with existing R&D platforms.

If you’re ready to fix data architecture problems at their source and regain freedom to innovate and scale, explore Sample Intelligence.

QuartzBio Sample Intelligence - Automated Unification of Sample Ecosystem

Watch a demo

Case Study: How a top 5 pharma doubled trial capacity and eliminated hidden data loss

“With QuartzBio, we spend 85% less time on sample-related tasks.”
–Top Biopharma

A Top 5 pharma discovered that outdated sample ops workflows were putting their pipeline at risk. With QuartzBio, they addressed fragmented data, manual workflows, and lack of visibility across the sample lifecycle, achieving:

Harmonized APIs across all vendors → architecture standardization
90% reduction in data wrangling → operational efficiency at scale
No re-architecture required → minimized disruption risk
Improved interoperability → stronger enterprise data ecosystem

View Case Study

Evolve your architecture—without rebuilding it.

In 15 minutes, we’ll help you identify where fragmented sample data is limiting your architecture—and how to standardize and scale without disrupting your existing stack.

Identify the biggest data architecture risks in your sample ecosystem:

Schedule My 15-min Executive Walkthrough

QuartzBio Certifications Security Compliance

QuartzBio is the only company purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, our solutions transform fragmented data into actionable intelligence, enabling conversational insights into your unified ecosystem of sample, clinical, and biomarker data.